Geode Capital Management
NVCT icon

Geode Capital Management’s Nuvectis Pharma NVCT Stock Holding History

Geode Capital Management’s Portfolio NVCT Stock Details NVCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.95M Buy
432,273
+48,168
+13% +$539K ﹤0.01% 2664
2026
Q1 		$2.97M Buy
384,105
+20,081
+6% +$172K ﹤0.01% 2975
2025
Q4 		$2.75M Buy
364,024
+38,291
+12% +$250K ﹤0.01% 3052
2025
Q3 		$1.96M Buy
325,733
+40,401
+14% +$278K ﹤0.01% 3186
2025
Q2 		$2.13M Buy
285,332
+149,999
+111% +$1.36M ﹤0.01% 3117
2025
Q1 		$1.32M Buy
135,333
+56,090
+71% +$404K ﹤0.01% 3204
2024
Q4 		$429K Sell
79,243
-473
-0.6% -$2.96K ﹤0.01% 3652
2024
Q3 		$501K Buy
79,716
+26,489
+50% +$174K ﹤0.01% 3580
2024
Q2 		$337K Sell
53,227
-81,301
-60% -$553K ﹤0.01% 3724
2024
Q1 		$1.1M Buy
134,528
+2,871
+2% +$24.4K ﹤0.01% 3330
2023
Q4 		$1.1M Buy
131,657
+1,994
+2% +$17.8K ﹤0.01% 3324
2023
Q3 		$1.67M Buy
129,663
+17,127
+15% +$248K ﹤0.01% 3130
2023
Q2 		$1.8M Buy
112,536
+77,514
+221% +$1.24M ﹤0.01% 3147
2023
Q1 		$459K Buy
35,022
+3,654
+12% +$37K ﹤0.01% 3674
2022
Q4 		$235K Sell
31,368
-73
-0.2% -$523 ﹤0.01% 4008
2022
Q3 		$222K Buy
31,441
+7,474
+31% +$69.6K ﹤0.01% 4145
2022
Q2 		$268K Buy
23,967
+9,145
+62% +$113K ﹤0.01% 4090
2022
Q1 		$109K Buy
+14,822
New +$103K ﹤0.01% 4629

Other funds holding NVCT

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return
OCM
Occam Crest Management Darien, Connecticut $193M AUM 233.09% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
BWP
Baldwin Wealth Partners Marion, Massachusetts $1.53B AUM 28.5% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Geode Capital Management's NVCT Position: Q2 2026 in Review

Geode Capital Management increased its Nuvectis Pharma (NVCT) stake by 13% in Q2 2026, buying an estimated $539K and bringing the position to 432,273 shares worth $7.95M. The position accounts for ﹤0.01% of the portfolio, ranked #2664.

Geode Capital Management first reported a position in NVCT in Q1 2022 and has held it in 18 quarters since. 83 funds tracked by Wall St. Rank hold NVCT as of Q2 2026.

  • Geode Capital Management held 432,273 shares of Nuvectis Pharma worth $7.95M as of Q2 2026.
  • Geode Capital Management bought 48,168 Nuvectis Pharma shares in Q2 2026, an estimated $539K.
  • Nuvectis Pharma made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #2664 holding.
  • Geode Capital Management first reported a position in Nuvectis Pharma in Q1 2022 and has held it in 18 quarters since.
  • 83 funds tracked by Wall St. Rank held Nuvectis Pharma as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.